Background
DISORDER
Buprenorphine-naloxone, an opioid agonist–antagonist, is frequently used as a medication to treat opioid use disorder (MOUD). Recent reviews show that buprenorphine-naloxone is an effective treatment for opioid detoxification, harm reduction, and maintenance therapy in inpatient and outpatient settings [Unfortunately, MOUD adherence is very low [Remarkably little research has been conducted to address adherence in MOUD patients. The American Society of Addiction Medicine’s 